8th Annual Advanced Therapy Development Congress28 - 29 October 2021 | London, UK
Organisations at the forefront of this field will present case studies on cutting-edge therapeutic innovations, clinical procedures, regulatory guidelines and commercial strategies to successfully bring to market transformative advanced therapies.
The Advanced Therapy Development Congress includes…
Over 250 cell & gene therapy, stem cell development, market access and regulatory attendees representing global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions.
Over 45 presentations and case studies focussed on the key strategies delivering advanced therapies into the clinic, from developing innovative targets to establishing clear regulatory guidelines
PLUS interactive opportunities including:
- Workshop: Investing in Cell & Gene Therapies
- Workshop: Delivering Cell Therapies for Solid Tumours
- Workshop: Aligning Clinical and Manufacturing Teams for Successful Advanced Therapy Development
- Workshop: Global Harmonisation on Regulatory Needs from Clinical Trials
This Year's Agenda at a Glance
Cell Therapy Development
- NK, TCR, Innate Killer Cell Therapies
- Developing reliable and sensitive tools to optimise safety & efficacy in cell therapies
Stem Cell Therapy Development
- Delivering stem cell therapies from discovery to the clinic
Cell and Gene Therapies
- Effective testing, validation and characterisation approaches
- Safety & efficacy considerations in next-gen technologies
